CohBar Granted US Patent Covering CB4211 Compositions and Use for Treating Nonalcoholic Steatohepatitis (NASH)

CohBar, Inc. announced the United States Patent and Trademark Office has granted a patent, US No. 11,111,271, covering CohBar’s lead candidate CB4211 and related compositions, as well as methods of treatment, including methods of treating NASH.